Member Info for Wisheyedbortum

Knowing how leaky the AIM is I would agree that this is probably a treeshake at a 14% drop.

Not quite. The SNG therapy induces the production of interferon in older patients who would normally be very slow to do so, which is why they are most at risk. By the sound of it, affimers will halt the virus and the stem cell therapy will repair the damage.

The thing that astonishes me is the sheer ignorance of the statement "who needs Affimers". Have you any Idea of the size of the antibody market that Avacta can just walk into? Have you any idea of the size of the cancer treatment market that Avacta is on the verge of helping. Let NCYT have their day and good luck to them, why not. Avacta's potential is far greater than NCYT will ever be. Covid 19 is just a bus stop, not the terminus.

VRS has turned out to be (at the moment) all hot air based on a massive deal with China which hasn't materialized. I have always had a holding in AVCT, but I am now fully loaded having studied the company for many moons. Thank you for your reports which I believe has cemented many investors' beliefs and research into Avacta, including mine.

I did the same thing with VRS. So much good news on the horizon that I dare not sell, so over the next few months my holding dwindled by £56k. I vowed never to do that again, but Avacta is different.....isn't it?

....Ratliff. I enjoyed that one.

That’s the first time that I have had three of my shareholding’s affected by one collaboration, and to be honest, I fully expected this to happen knowing the filtration capabilities of affimers.

I see that TW, apart from calling us "thick as sh*t investors", "morons" and "mugs" is now encouraging us to short the stock. What a towrag that bloke is.

No, because I am trading ITM.

Avacta has tried Carclo before when AX1 (Midas) was being developed, but they couldn’t meet the exacting requirements. Maybe the test strip is much easier to produce.

And yet TW says it’s going away. Testing is going to be with us for a very long time, even a way of life.

I’ve met him on a number of occasions and he is a super guy, very bright and shrewd with it. Very safe hands.

You also have to take into consideration that the fundraise Will also allow shelved projects to be brought back on stream, and we do not know what those projects are or how long they will take to become live. Unless you are privy to exactly what Avacta has on the go, I suggest that “nothing between here and cancer” sounds like TW rhetoric.

China now fears a second wave. This isn’t going away in a hurry.

I certainly did. I pared back my other holdings to buy more here, because I’m not sure that this price will be available for much longer.

I consigned this lot to the bin ages ago, now there’s another placing undoubtably followed by the inevitable consolidation, reducing my holding to zilch, worth stuff all and for what?

If you hold AIM shares for more than two years, they are exempt from inheritance tax.

I think that the placing was unforeseen by Avacta. The company is looking for a partner to fast track the Covid 19 “cure” through which would fast track the testing of affimers in humans. This would also fast track the use of affimers in Avacta’s cancer drug delivery tests which would be of huge benefit to Avacta, so I think that a big pharma has requested a “donation” towards the costs of this research as it will help Avacta enormously. Just a thought.

The last thing I want is for Avacta to come off of AIM. At my age, you have to start thinking about inheritance tax.

I bought £10k worth this morning at 174p which I am reasonably pleased with. It may climb back, it may not, but long term is what matters.